Cardiovascular uses of cannabinoid compounds

US5939429A · kind A · utility

Assignee

• Virginia Commonwealth University · US

Inventors

• George Kunos · Bethesda, US
• Karoly Varga · Richmond, US
• Jens Wagner · Richmond, US
• Earl F. Ellis · Midlothian, US
• Aron Sanyal · Mechanicsville, US

Key dates

• Filing date: Sep 29, 1998
• Grant date: Aug 17, 1999
• Expiry date: Sep 29, 2018

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K31/352
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Hemorrhagic shock and in other conditions associated with excessive vasoconstriction, such as hypertension, peripheral vascular disease, cirrhosis of the liver, or certain forms of angina pectoris can be treated by using agonists of CB1 receptors as well as other cannabinoid receptors. In addition, it has been determined that in septic shock and cirrhosis of the liver when hypotension is due to activation of macrophages by bacterial endotoxin, the use of a drug that selectively blocks CB1 receptors or other cannabinoid receptors may be of therapeutic value by preventing or attenuating the endotoxin-induced hypotension.